At Business Growth Point, we focus on what really matters — practical strategies, real-world examples, and proven tactics to grow your business.
Regeneron Buys 23andMe: $256M Deal After Bankruptcy Shakes Genetic Testing Giant

Regeneron Pharmaceuticals has agreed to acquire the bankrupt genetic testing company 23andMe for $256 million, marking a significant shift in the consumer genomics landscape. The deal, expected to close in the third quarter of 2025 pending court and regulatory approvals,…









